We are live on
!
Find out more
MC
Metavasi Capital Portfolio holdings
AUM
$287M
1-Year Est. Return
97.9%
This Fund
S&P 500
This Quarter
Est. Return
+18.64%
1 Year Est. Return
+97.9%
3 Year Est. Return
+839.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
+$79.6M
(+45%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-12.39%
Top 10 Holdings %
Top 10 Hldgs %
75.45%
Holding
42
New
13
Increased
6
Reduced
8
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$9.08M |
| 2 |
CarGurus
CARG
|
+$7.43M |
| 3 |
Global E Online
GLBE
|
+$5.29M |
| 4 |
CFLT
Confluent
CFLT
|
+$4.23M |
| 5 |
Advanced Micro Devices
AMD
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$11.3M |
| 2 |
WW
WW International
WW
|
+$10.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.77M |
| 4 |
Charter Communications
CHTR
|
+$9.24M |
| 5 |
WIX.com
WIX
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.9% |
| 2 | Technology | 20.11% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Communication Services | 10.42% |
| 5 | Financials | 7.81% |
Similar funds
RSC
PCM
SRWM
OCM
ORC
AWMT
TWM
QFW
Metavasi Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Metavasi Capital held 42 positions worth $257M, up 45% from $178M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Metavasi Capital withdrew a net $31.9M in Q4 2023, closing 14 positions and reducing 8 holdings. Its most notable exit was Eli Lilly, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Metavasi Capital opened a new position in Coupang worth $8.9M.
- Metavasi Capital's largest Q4 2023 buy was Coupang: 550,000 shares worth $8.9M.
- Metavasi Capital added most to Amazon in Q4 2023, an estimated $4.07M increase.
- Metavasi Capital's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $9.77M.
- Metavasi Capital fully exited Eli Lilly in Q4 2023, selling an estimated $11.3M.
- Metavasi Capital's ten largest holdings make up 75% of its $257M portfolio in Q4 2023.
- Metavasi Capital opened 13 new positions and closed 14 in Q4 2023.
- Metavasi Capital's portfolio value rose 45% quarter-over-quarter to $257M.
Based on Metavasi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.